Latvia vs Netherlands: Proportion of isolates with resistance to azithromycin reported to
Latvia
14.3
in 2019
Netherlands
14.8
in 2020
Latvia rank
11th
Netherlands rank
10th
Proportion of isolates with resistance to azithromycin reported to over time
- Latvia
- Netherlands
How they compare
Netherlands currently reports 14.8 against 14.3 in Latvia, a difference of 0.5.
The two have swapped places 4 times across 10 shared years of data; in 2009 it was Netherlands ahead.
Latvia ranks 11th and Netherlands ranks 10th of 47 countries.
Across the 2 decades both report, Latvia averaged higher in 1 and Netherlands in 1.
Head to head by decade
| Decade | Latvia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 2.63 | 2.63 | Netherlands |
| 2010s | 4.86 | 3.98 | 0.8791 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, Latvia or Netherlands?
- Netherlands, at 14.8 against 14.3 in Latvia as of 2020.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between Latvia and Netherlands?
- 0.5, with Netherlands ahead.
- How many years of comparable data are there for Latvia and Netherlands?
- 10 years are reported by both, from 2009 to 2018.
- How do Latvia and Netherlands rank globally for proportion of isolates with resistance to azithromycin reported to?
- Latvia ranks 11th and Netherlands ranks 10th of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.